During August 2024, the CIDG contributed to one new Cochrane review in Issue 8, 2024 of the Cochrane Database of Systematic Reviews.
New Cochrane review
- De Rop L, Bos DAG, Stegeman I, Holtman G, Ochodo EA, Spijker R, Otieno JA, Alkhlaileh F, Deeks JJ, Dinnes J, Van den Bruel A, McInnes MDF, Leeflang MMG, Verbakel JY. Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID‐19 in people with SARS‐CoV‐2. Cochrane Database of Systematic Reviews 2024, Issue 8. Art. No.: CD015050. DOI: 10.1002/14651858.CD015050.pub2
Other publications
- Fox T, Hunt BJ, Ariens RAS, Towers GJ, Lever R, Garner P, Kuehn R. Systematic reviews of clinical laboratory studies: pilot risk of bias tool developed by consensus. Cochrane Evidence Synthesis and Methods. 2024;2:e12098. DOI: 10.1002/cesm.12098
Other news
Global Evidence Summit 2024
Two of our editorial base staff will be attending the upcoming Global Evidence Summit to be held in Prague from 10 – 13 September 2024 and both will be presenting posters:
- Tilly Fox (Poster): Developing systematic reviews on emerging topics: production of impactful intervention reviews with a limited evidence base (Wed 11 Sept 12.30-2pm)
- Dr Kerry Dwan (Poster): Let’s create Methods and Statistics Tutorials: working together to develop innovative (and publishable!) learning resources for evidence synthesis (Wed 13 Sept 12.00-1.30pm).
Do continue to check our CIDG and READ-It websites for updates, and follow us on X .
The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals.